In recent years, there have been rapid technological advancements in the field of medical research, particularly in organ-on-a-chip and microfluidic technologies.
Hubrecht Organoid Technology (HUB), and the health insurance companies CZ, Zilveren Kruis, and Menzis announced today that they will start a €3 million validation trial for use of HUB Organoid Technology...